- Price:
- $17.66
- Open:
- $17.55
- Previous close:
- $17.13
- Day's range:
- $16.69 - $17.74
- Year's range:
- $5.65 - $25.74
- Net Income per Share:
- 0.08
- Price-to-Earnings ratio:
- 220.75
- 52-week Price Range:
- $16.69
- Volume:
- $7,554,879.00
- Average volume:
- $8,473,445.00
Company profile for Hims & Hers Health, Inc.
Hims & Hers Health, Inc. is a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals. It offers a range of health and wellness products and services available to purchase on its websites and mobile application directly by customers. Prescription medication can be purchased on a recurring basis and ongoing care from healthcare providers is also available. The company’s curated non-prescription products include vitamin C, melatonin, biotin, and collagen protein supplements in the wellness category; moisturizer, serums, and face wash in the skincare category; condoms, climax delay spray and wipes, vibrators, and lubricants in the sexual health and wellness category; and shampoos, conditioners, scalp scrubs, and topical treatments, such as minoxidil in the hair care category. In addition, Hims & Hers Health, Inc. provides medical consultation services, as well as health and wellness products through wholesale partners.
Hims & Hers Health, Inc. was founded in 2017 by Andrew Dudum, who serves as the company’s CEO. The company has raised over $200 million in venture capital funding since its founding, with investors including Thrive Capital, Forerunner Ventures, and 8VC. In 2018, the company expanded its services to include mental health and dermatology services. In 2020, it began offering telehealth services in Canada. The company is currently valued at over $1 billion and has more than 500 employees.
- Stock exchanges:
- NYSE
- Sector:
- Consumer Defensive
- Industries:
- Ticker:
- HIMS
- CIK:
- 0001773751
- ISIN:
- US4330001060
- Website:
- https://www.forhims.com
- Phone:
- 415 851 0195
- Origin:
- United States
- Employees:
- 651